U.S. Markets open in 5 hrs 20 mins

Accuray Incorporated (ARAY)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
4.00-0.10 (-2.44%)
At close: 4:00PM EDT
People also watch
HNSNANGOVARABMDATEC
Full screen
Previous Close4.10
Open4.10
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.95 - 4.10
52 Week Range3.85 - 6.39
Volume580,070
Avg. Volume526,123
Market Cap332M
Beta2.10
PE Ratio (TTM)-10.26
EPS (TTM)-0.39
Earnings DateAug 15, 2017 - Aug 21, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.25
Trade prices are not sourced from all markets
  • Market Realist2 days ago

    Varian’s Oncology Business Grows in Emerging Markets

    Varian Medical Systems’ (VAR) oncology business reaches around the globe. With a market share of ~60%, It is a leading player in the space. Other major medical device companies in the…

  • PR Newswire3 days ago

    Accuray To Report Fiscal 2017 Fourth Quarter And Full Year Results On August 22, 2017

    SUNNYVALE, Calif. , Aug. 14, 2017 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2017 ended June 30, 2017 on Tuesday, August 22, 2017 after ...

  • PR Newswire13 days ago

    First Radixact™ System Research Results Presented at the American Association of Physicists in Medicine Annual Meeting

    SUNNYVALE, Calif., Aug. 4, 2017 /PRNewswire/ -- Accuray Incorporated (ARAY) announced today that the first studies validating the benefits of the leading-edge Radixact™ System were presented at the 59th Annual Meeting of the American Association of Physicists in Medicine (AAPM) held in Denver, Colorado, July 30 through August 3, 2017. This smart radiation therapy system represents the next generation in TomoTherapy® treatment delivery, significantly increasing treatment speed and ease of use. The Radixact System enables clinicians to treat a wide range of cancer cases, from initial plan delivery to adaptive therapy to complex retreatments, with precision and increased efficiency.